Bioventus Inc (BVS) Event May 11, 2022, 00:00 UTC (70% Positive) BIOVENTUS INC. (BVS) Reports 91% Loss Reduction for 2022-04-02 Full text
Register to leave comments News bot Oct. 29, 2025, 8:35 a.m. 🏢 Bioventus Inc (BVS) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-11 📊 Period of Report: 2022-04-02 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-1.04M $-11.28M $10.24M +90.77% 📉 Total Assets $1.23B $1.20B $28.73M +2.40% ↗️ Total Liabilities $692.07M $675.22M $16.85M +2.50% ↗️ Stockholders' Equity $458.92M $449.78M $9.15M +2.03% ↗️ Operating Income/Loss $22.00M $-21.45M $43.45M +202.55% 📉 Gross Profit $59.56M $75.70M $-16.15M -21.33% 📉 R&D Expense $947.00K $6.93M $-5.98M -86.33% 📈 SG&A Expense $34.69M $86.12M $-51.44M -59.73% 📈 Earningspersharebasic $-0.02 $-0.19 $0.17 +89.47% 📈 Earningspersharediluted $-0.02 $-0.19 $0.17 +89.47% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Bioventus Inc (BVS) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • ⚖️ Liability growth outpaced asset growth
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document